Categories: International

US begun phase one clinical Human trial of coronavirus vaccine

The United State has begun phase one of the clinical Human trial of an investigational vaccine designed to protect against the coronavirus disease which has claimed the lives of over 7,000 people globally.

Important Facts of Covid-19 vaccine trial:

  • The trial began at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle as the first participant received the investigational vaccine.
  • The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is funding the trial.
  • The open-label trial will enrol 45 healthy adult volunteers aged 18 to 55 years over approximately six weeks.
  • The study participants will receive two doses of the vaccine via intramuscular injection in the upper arm approximately 28 days apart.
  • The vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts.
  • The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial. CEPI so far has secured USD 760 million toward its USD 1 billion funding target, with multi-year funding from Norway, the UK, Germany, Japan, Canada, Ethiopia, Australia, the Bill & Melinda Gates Foundation, and Wellcome.
  • The CEPI set up to accelerate the development of vaccines against emerging infectious diseases, made an urgent call for USD 2 billion to support the development of a vaccine against the virus responsible for COVID-19.

Important takeaways for all competitive exams:

  • COVID-19 cases were first identified in December 2019 in China’s Wuhan in Hubei province. As of March 15, the WHO has reported 153,517 cases of COVID-19 and 5,735 deaths worldwide.

Find More International News

Sumit Arora

As a team lead and current affairs writer at Adda247, my role involves researching and creating informative and engaging content aimed at helping candidates prepare for national and state-level competitive government exams. I specialize in delivering insightful articles that keep aspirants updated on the latest current affairs trends and developments. My primary focus is on educational excellence, ensuring that our readers are well-prepared and informed to face their exams with confidence. Through meticulously crafted content, I aim to guide and support candidates in their journey toward success.

Recent Posts

Celebrating Good Governance Day- Honouring Atal Bihari Vajpayee’s Legacy

Good Governance Day, also known as Sushashan Diwas, is observed annually on December 25 in…

5 hours ago

President Appoints New Governors For Five States

In a significant move aimed at reorganizing governance and addressing political and administrative challenges, President…

8 hours ago

December 25th Current Affairs Challenge

Exams such as SSC, Banking, Railways, and state-level tests offer paths to prestigious positions in…

15 hours ago

What is the Old Name of Mysore?

Mysore, a city in the southern state of Karnataka, India, is famous for its rich…

1 day ago

India Squad For Champions Trophy 2025

The upcoming Champions Trophy 2025 marks the ninth edition of the ICC Champions Trophy, featuring…

1 day ago

ICC Champions Trophy Schedule 2025 Announced- India vs Pakistan

The 2025 ICC Champions Trophy is set to mark the ninth edition of this prestigious…

1 day ago